Nicotinamide combined with gemcitabine is an immunomodulatory therapy that restrains pancreatic cancer in mice
Benson Chellakkan Selvanesan(The University of Texas MD Anderson Cancer Center), Claudia Gravekamp(Albert Einstein College of Medicine)
Cited by 4
Related Papers
Myeloid-derived suppressor cells have a central role in attenuated Listeria monocytogenes-based immunotherapy against metastatic breast cancer in young and old mice
|British Journal of Cancer|2013|142
Nicotinamide combined with gemcitabine is an immunomodulatory therapy that restrains pancreatic cancer in mice
|Journal for ImmunoTherapy of Cancer|2020|28
Lymphocyte antigen 6K signaling to aurora kinase promotes advancement of the cell cycle and the growth of cancer cells, which is inhibited by LY6K-NSC243928 interaction
|Cancer Letters|2023|4
Immunotherapy for ovarian cancer is improved by tumor-targeted delivery of a neoantigen surrogate
|bioRxiv (Cold Spring Harbor Laboratory)|2023|1